Washington, D.C.-based George Washington University Hospital could be stripped of regulatory approval for its kidney and pancreas transplant program due to a recent court ruling, according to the Washington Business Journal.
GW University Hospital restarted its transplant program in January 2015 after receiving a certificate of need to do so from an administrative court. However, earlier this month, a panel from the U.S. Court of Appeals for the District of Columbia ruled the administrative court exceeded its authority when it granted the CON.
Columbia, Md.-based MedStar Health, which opposed GW University Hospital's CON request, is the petitioner in the appellate filing, according to the Washington Business Journal.
The appeals court sent the case back to city regulators, who will determine whether the approval should be modified or retracted, according to the report.
GW University Hospital officials said physician's at the hospital's Transplant Institute have performed 72 kidney transplants since it was established in 2015, according to the report.
More articles on legal and regulatory issues:
OIG: Kindred Healthcare fined more than $3M for failing to correct improper billing
ACLU sues Colo. Medicaid for denying thousands hep C treatment
Appeals court clarifies reach of False Claims Act retaliation liability